Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  UnitedHealth Group    UNH

UNITEDHEALTH GROUP

(UNH)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 184 828 201 159 226 247 242 409 261 915 282 958
EBITDA 15 335 17 454 19 772 22 275 24 816 27 467
Operating profit (EBIT) 13 280 15 209 17 344 19 564 21 933 24 322
Pre-Tax Profit (EBT) 12 213 14 023 15 944 17 793 20 139 22 556
Net income 7 237 10 558 11 986 13 725 14 935 16 855
P/E ratio 21,4x 20,6x 20,4x 19,8x 17,9x 15,7x
EPS ( $ ) 7,48 10,7 12,2 14,2 15,7 18,0
Dividend per Share ( $ ) 2,38 2,88 3,45 4,19 4,65 5,05
Yield 1,48% 1,30% 1,38% 1,48% 1,65% 1,79%
Reference price ( $ ) 160,040 220,460 249,120 282,000 282,000 282,000
Announcement Date 01/17/2017
10:55am
01/16/2018
10:55am
01/15/2019
10:55am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt 19 695 20 113 25 688 29 940 26 442 20 812
Finance - - - - - -
Operating income (EBITDA) 15 335 17 454 19 772 22 275 24 816 27 467
Leverage
(Debt/EBITDA)
1,28x 1,15x 1,30x 1,34x 1,07x 0,76x
Capital Expenditure 1 705 2 023 2 063 2 098 2 278 2 545
Free Cash Flow (FCF) 8 090 11 573 13 650 15 323 17 322 19 550
Book Value Per Share (BVPS) ( $ ) 40,2 49,3 53,9 61,3 68,2 77,0
Cash Flow per Share ( $ ) 10,1 13,8 16,0 15,3 19,7 21,1
Announcement Date 01/17/2017
10:55am
01/16/2018
10:55am
01/15/2019
10:55am
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 267 171 M $ -
Entreprise Value (EV) 297 111 M $ 293 613 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 19,8x 17,9x
Capitalization / Revenue 1,10x 1,02x
EV / Revenue 1,23x 1,13x
EV / EBITDA 13,3x 12,0x
Yield (DPS / Price) 1,48% 1,65%
Price to book (Price / BVPS) 4,60x 4,14x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 8,07% 8,37%
Operating Leverage (Delta EBIT / Delta Sales) 1,79x 1,50x
Net Margin (Net Profit / Revenue) 5,66% 5,70%
ROA (Net Profit / Asset) 8,64% 8,69%
ROE (Net Profit / Equities) 25,0% 25,0%
Rate of Dividend 29,4% 29,5%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   0,87% 0,87%
Cash Flow / Sales 6,00% 7,11%
Capital Intensity (Assets / Sales) 0,66x 0,66x
Financial Leverage (Net Debt / EBITDA) 1,34x 1,07x
EPS & Dividend